BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 175 filers reported holding BLUEPRINT MEDICINES CORP in Q4 2017. The put-call ratio across all filers is 0.27 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $957,000 | +125.2% | 8,883 | +98.0% | 0.00% | – |
| Q1 2024 | $425,000 | -78.6% | 4,487 | -79.2% | 0.00% | – |
| Q4 2023 | $1,987,000 | +258.0% | 21,529 | +94.4% | 0.00% | – |
| Q3 2023 | $555,000 | +27.3% | 11,073 | +60.5% | 0.00% | – |
| Q2 2023 | $436,000 | +50.3% | 6,899 | +6.8% | 0.00% | – |
| Q1 2023 | $290,000 | -45.8% | 6,458 | -47.2% | 0.00% | – |
| Q4 2022 | $535,000 | +117.5% | 12,241 | +227.1% | 0.00% | – |
| Q3 2022 | $246,000 | +2.9% | 3,742 | -20.9% | 0.00% | – |
| Q2 2022 | $239,000 | -50.6% | 4,732 | -37.6% | 0.00% | – |
| Q1 2022 | $484,000 | -74.7% | 7,579 | -57.6% | 0.00% | – |
| Q4 2021 | $1,914,000 | +104.9% | 17,872 | +96.8% | 0.00% | – |
| Q3 2021 | $934,000 | -59.3% | 9,080 | -65.2% | 0.00% | -100.0% |
| Q2 2021 | $2,296,000 | -54.7% | 26,111 | -49.9% | 0.00% | 0.0% |
| Q1 2021 | $5,065,000 | -19.7% | 52,088 | -7.3% | 0.00% | -50.0% |
| Q4 2020 | $6,304,000 | +22.1% | 56,198 | +0.9% | 0.00% | 0.0% |
| Q3 2020 | $5,161,000 | -6.4% | 55,680 | -21.2% | 0.00% | 0.0% |
| Q2 2020 | $5,514,000 | +37.2% | 70,690 | +2.8% | 0.00% | 0.0% |
| Q1 2020 | $4,020,000 | +545.3% | 68,747 | +782.7% | 0.00% | – |
| Q4 2019 | $623,000 | +165.1% | 7,788 | +143.8% | 0.00% | – |
| Q3 2019 | $235,000 | -87.5% | 3,195 | -84.0% | 0.00% | -100.0% |
| Q2 2019 | $1,879,000 | -17.4% | 19,925 | -29.9% | 0.00% | 0.0% |
| Q1 2019 | $2,274,000 | -61.6% | 28,406 | -74.2% | 0.00% | -66.7% |
| Q4 2018 | $5,925,000 | -27.2% | 109,921 | +5.3% | 0.00% | 0.0% |
| Q3 2018 | $8,144,000 | +70.4% | 104,347 | +38.6% | 0.00% | +50.0% |
| Q2 2018 | $4,780,000 | +95500.0% | 75,299 | +141973.6% | 0.00% | – |
| Q1 2018 | $5,000 | -78.3% | 53 | -83.0% | 0.00% | – |
| Q4 2017 | $23,000 | -99.7% | 312 | -99.7% | 0.00% | -100.0% |
| Q3 2017 | $8,292,000 | +138100.0% | 119,025 | +96668.3% | 0.00% | – |
| Q2 2017 | $6,000 | -76.9% | 123 | -80.9% | 0.00% | – |
| Q1 2017 | $26,000 | +13.0% | 643 | -22.2% | 0.00% | – |
| Q4 2016 | $23,000 | – | 827 | +6261.5% | 0.00% | – |
| Q4 2015 | $0 | -100.0% | 13 | -96.9% | 0.00% | – |
| Q3 2015 | $9,000 | -40.0% | 419 | -27.0% | 0.00% | – |
| Q2 2015 | $15,000 | – | 574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 559,381 | $41,098,000 | 15.69% |
| Casdin Capital, LLC | 940,000 | $69,061,800,000 | 7.15% |
| Ghost Tree Capital, LLC | 325,000 | $23,878,000 | 6.08% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,418,704 | $104,232,000 | 4.96% |
| DAFNA Capital Management LLC | 123,218 | $9,053,000 | 3.40% |
| BVF INC/IL | 437,565 | $32,148,000 | 3.38% |
| Opaleye Management Inc. | 105,000 | $7,714,000 | 2.79% |
| Cormorant Asset Management, LP | 493,000 | $36,221,000 | 2.20% |
| Novo Holdings A/S | 170,667 | $12,539,000 | 2.15% |
| Artal Group S.A. | 600,000 | $44,082,000 | 1.77% |